The St. Baldrick’s Foundation and the American Cancer Society are collaborating to provide funding to advance innovative translational pediatric cancer research conducted within the context of a clinical trial. Studies may include analysis of clinical data and biospecimens collected from children enrolled in a clinical trial.
These investigations should be designed to provide new knowledge regarding mechanisms for novel agents or combination regimens, treatment resistance, novel biomarkers, toxicity, and insights for approaches to precision medicine. We anticipate this funding will stimulate a wide range of new research, stemming from on-going or recently completed patient trials to accelerate progress in childhood cancer.
Deadline for LOI: Dec. 5, 2022
Eligible Investigators: Must have a doctoral-level degree and have a full-time faculty position or equivalent at a college, university, medical school, or eligible not-for-profit research organization within the United States. There are no citizenship restrictions.
Eligible Institutions: Applications may be submitted by a college, university, medical school, or other eligible not-for-profit research organization within the United States, its territories, and the Commonwealth of Puerto Rico.
Grant Term and Budget: The award is for a 2-year term with $100k direct cost per year, plus 20% allowable indirect cost.
